Research Article
The Role of Parathyroid Hormone and Vitamin D Serum Concentrations in Patients with Cardiovascular Diseases
Table 3
Laboratory findings among all examined groups.
| | | HF | | | CAD | | | No CAD | | | N-IHF | IHF | | IHF | CAD N-HF | | N-IHF | N-HF & N-CAD | | Parameter | Versus | | Versus | | Versus | |
| 25(OH)D (ng/ml) | 29.25 | 32.29 | ns | 32.29 | 29.47 | ns | 29.25 | 31.00 | ns | Ca2+ (mmol/l) | 2.36 | 2.32 | ns | 2.32 | 2.37 | ns | 2.36 | 2.37 | ns | P (mmol/l) | 1.21 | 1.23 | ns | 1.23 | 1.18 | ns | 1.21 | 1.18 | ns | PTH (pg/ml) | 85.26 | 84.91 | ns | 84.91 | 64.24 | 0.06 | 85.26 | 62.67 | ns | eGFR (ml/min/1.732) | 67.38 | 79.14 | ns | 79.14 | 81.15 | ns | 67.38 | 87.88 | ns | Creatinine (mmol/l) | 96.00 | 87.89 | ns | 87.89 | 84.11 | ns | 96.00 | 71.06 | ns | ALT (IU/l) | 35.23 | 28.84 | ns | 28.84 | 29.73 | ns | 35.23 | 37.47 | ns | AST (IU/l) | 38.69 | 34.41 | ns | 34.41 | 26.32 | ns | 38.69 | 30.53 | ns | HGB (g/dl) | 13.52 | 13.48 | ns | 13.48 | 13.51 | ns | 13.52 | 13.80 | ns | HCT (%) | 42.44 | 40.86 | ns | 40.86 | 41.36 | ns | 42.44 | 42.97 | ns | RBC (106/ul) | 4.61 | 4.42 | ns | 4.42 | 4.43 | ns | 4.61 | 4.53 | ns | PLT (103/ul) | 169.62 | 215.78 | 0.04 | 215.78 | 212.29 | ns | 169.62 | 202.88 | ns | WBC (103/ul) | 6.68 | 7.79 | ns | 7.79 | 7.04 | 0.04 | 6.68 | 5.87 | ns |
|
|
N-IHF: nonischemic heart failure; IHF: ischemic heart failure; CAD N-HF: coronary artery disease without heart failure; N-HF&N-CAD: without coronary artery disease nor heart failure; 25(OH)D: 25-hydroxyvitamin D; Ca2+: total calcium; P: phosphorus; PTH: parathyroid hormone; eGFR: estimated glomerular filtration rate; ALT: alanine aminotransferase; AST: aspartate aminotransferase; HGB: hemoglobin; HCT: hematocrit; RBC: red blood cells; PLT: platelets; WBC: white blood cells.
|